TriLink Signs Sales, License Agreement With Glen Research

TriLink has signed a sales and license agreement with Glen Research to sell TriLink’s CleanAmp Amidites. Glen Research can now sell the patented CleanAmp Amidites to third parties for use in the production of CleanAmp Primers.

CleanAmp technology offers a less expensive approach to high stringency PCR. CleanAmp is a unique solution, where the primer or dNTP components of the PCR reaction mix, rather than the enzymes are modified.

Richard Hogrefe, CEO of TriLink, said: “TriLink and Glen Research have a long standing relationship built on a shared interest in advancing science through the highest quality reagents and technical expertise. We feel Glen Research is the perfect partner for bringing CleanAmp Amidites to the marketplace.”